InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Rebel Vivienne I. Officer active across 1 company, notably bioAffinity Technologies, Inc.. Aggregated, 2 disclosures have been logged. History available since 17 November 2022. The latest transaction was disclosed on 31 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations